For example, in two distinct experiments, enhanced sensitivity of breast cancer cells to Adriamycin and Trastuzumab is shown when SNHG7 is silenced or its target sponged miRNA (miR-34a or miR-186, respectively) is overexpressed (Li et al., 2020a; Zhang et al., 2020b). The gene discussed is SNHG7; the disease is breast cancer.